SOUTH SAN FRANCISCO, March 8, 2022 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, today announced it will launch an industry-changing new solution during the 2022 HIMSS Global Health Conference & Exhibition in Orlando, Fla., that touches every major segment of the healthcare industry.
"HIMSS22 is one of the largest healthcare technology conferences in the world, so we could not think of a better place to unveil our exciting new and innovative solution that will bring a welcome change to a major aspect of healthcare delivery as we know it," said Bob Katter, president of FDB. "Our new offering is an exciting example of what happens when you turn 'what if' into what is. We started with some practical questions and wound up with something that is truly amazing."
Katter added: "We are confident that our announcement and details of our solution's launch will be of major interest and widely embraced. Our work developing deep and trusted knowledge of medications and healthcare workflows and connecting with multiple stakeholders throughout the healthcare system over the last four decades has led us to this point, and we are looking forward to sharing our new offering in Orlando."
FDB will announce details of the new solution on Tuesday, March 15. An accompanying press release and other background information will be issued on that day. Members of the media are encouraged to visit FDB at booth #3659.
FDB PatientFirst Solutions Yield Benefits
During HIMSS22, FDB will also be sharing news about how solutions within its FDB PatientFirst suite are delivering targeted and patient-focused context (e.g., lab results and clinical risk scores) and drug information to help clinicians make precise, evidence-based decisions. The FDB PatientFirst solution suite was developed to ensure the patient and their unique circumstances are at the center of clinical decision support (CDS) through targeted, actionable, and timely care guidance that helps improve outcomes and increase clinician satisfaction. The following offers a brief overview of what HIMSS22 attendees will discover:
MEDITECH Booth: 3311
Tuesday, March 15, 2022, 2 p.m.
Wednesday, March 16, 2022, 11:30 a.m.
"It is widely recognized that CDS needs to be more patient-specific and actionable to deliver higher impact," said Virginia Halsey, vice president of product management for FDB. "For too long, achieving that impact has required homegrown builds or complicated integrations with fledgling companies—often with a substantial maintenance burden. With FDB's PatientFirst approach, healthcare organizations can implement a next-generation CDS solution with highly regarded, professionally maintained medication content and with a partner that has a proven track record of integrating clinical content into the workflow."
Halsey added: "The implementation choices you make—or worse, don't make—are critical to your users' experience—and the impact of CDS—especially with highly dynamic medication information."
Solving Today's Healthcare Challenges
In addition to optimizing clinical decision support, representatives from FDB at HIMSS22 will also explain how other solutions help healthcare professionals address major care delivery and operational challenges facing health systems and pharmacies today. HIMSS22 attendees will learn the following:
'Pop In' for Conversation and Prizes
HIMSS22 attendees can view demonstrations of these solutions during HIMSS22 at the Orange County Convention Center exhibit hall booth #3659.
Attendees are invited to attend the following reception to learn more:
"Pop In" for Conversation and Prizes
Wednesday, March 16, 5 pm to 6 pm
HIMSS22 Exhibit Hall Booth #3659
Hosted by FDB, Zynx Health, and MCG
Complimentary gourmet popcorn gift to all attendees
Drawing for $1,000 Amazon gift card
About First Databank
FDB (First Databank) creates and delivers the world's most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our drug databases drive healthcare information systems that serve the majority of hospitals, physician practices, pharmacies, payers, and all other areas of healthcare and are used by millions of clinicians, business associates, and patients every day. For a complete look at our solutions and services, please visit https://www.fdbhealth.com/ or follow us on Twitter, LinkedIn and YouTube.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth or LinkedIn @Hearst-Health.
Amendola Communications for FDB
SOURCE First Databank